CYTH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.452600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.623800E-01
Normal-vs-Stage2
7.671600E-01
Normal-vs-Stage3
4.249200E-01
Normal-vs-Stage4
4.937000E-01
Stage1-vs-Stage2
3.230200E-01
Stage1-vs-Stage3
9.010800E-01
Stage1-vs-Stage4
7.131600E-02
Stage2-vs-Stage3
3.641400E-01
Stage2-vs-Stage4
5.913600E-02
Stage3-vs-Stage4
1.307550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.138800E-01
Normal-vs-AfricanAmerican
9.715200E-01
Normal-vs-Asian
5.579200E-01
Caucasian-vs-AfricanAmerican
6.632400E-01
Caucasian-vs-Asian
4.646200E-01
AfricanAmerican-vs-Asian
4.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.988400E-01
Normal-vs-Female
9.428800E-01
Male-vs-Female
7.888400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.565000E-01
Normal-vs-Age(41-60Yrs)
8.634400E-01
Normal-vs-Age(61-80Yrs)
6.095000E-01
Normal-vs-Age(81-100Yrs)
6.095400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.484200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.117400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.254400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.437960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.498350E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.513400E-01
Normal-vs-Daily Drinker
2.255600E-01
Normal-vs-Weekly Drinker
7.929600E-01
Normal-vs-Occasional Drinker
6.030000E-01
Normal-vs-Social Drinker
9.145000E-01
Non Drinker-vs-Daily Drinker
5.654600E-01
Non Drinker-vs-Weekly Drinker
5.962000E-02
Non Drinker-vs-Occasional Drinker
6.885800E-01
Non Drinker-vs-Social Drinker
9.564400E-02
Daily Drinker-vs-Weekly Drinker
4.170100E-02
Daily Drinker-vs-Occasional Drinker
3.428400E-01
Daily Drinker-vs-Social Drinker
2.294500E-02
Weekly Drinker-vs-Occasional Drinker
1.740560E-01
Weekly Drinker-vs-Social Drinker
7.363000E-01
Occasional Drinker-vs-Social Drinker
2.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.491800E-01
Normal-vs-Grade 2
9.146200E-01
Normal-vs-Grade 3
8.829600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.225000E-04
Grade 1-vs-Grade 3
1.098200E-02
Grade 1-vs-Grade 4
7.491800E-01
Grade 2-vs-Grade 3
4.647600E-01
Grade 2-vs-Grade 4
9.146200E-01
Grade 3-vs-Grade 4
8.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.868600E-01
Normal-vs-NonDiabetic
7.748400E-01
Diabetic-vs-NonDiabetic
2.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.944800E-01
Normal-vs-NoPancreatitis
7.320200E-01
Pancreatitis-vs-NoPancreatitis
8.016000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.157400E-01
Normal-vs-N1
8.405800E-01
N0-vs-N1
2.733000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.142000E-01
Normal-vs-TP53-NonMutant
5.837600E-01
TP53-Mutant-vs-TP53-NonMutant
6.777800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
